Effect of FK 506 in the treatment of autoimmune glomerulonephritis in Brown Norway rats

Nephron

Volumn 81, Issue 4, 1999, Pages 421-427

  Nakahama, H ^a   Obata, K ^a   Sugita, M ^a   Horio, M ^b   Oka, K ^c   Moriyama, T ^c  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Brown Norway rat; Fk 506; Mercuric chloride

Indexed keywords

IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; MERCURIC CHLORIDE; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; EPITHELIUM CELL; GLOMERULONEPHRITIS; HISTOLOGY; IMMUNOFLUORESCENCE; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032985525     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045326     Document Type: Article

References (28)

1. 2 in the rat. Its possible role in mercury induced glomerulonephritis. Eur J Immunol 1982;12:620-625.
2. 2 induced T and B cells to proliferate and differentiate in BN rats. Clin Exp Immunol 1988;71: 336-342.
3. 2 in the Brown Norway rat. Ann Immunol 1978;129C:777-792.
4. 2 in the rat. J Immunol 1981; 126:699-702.
5. 2-induced autoimmunity in Brown Norway rats. Nephrol Dial Transplant 1995;10: 2020-2026.
6. Sapin C, Druet E, Druet P: Induction of antiglomerular basement membrane antibodies in the Brown-Norway rat by mercuric chloride. Clin Exp Immunol 1977;28:173-179.
7. Fukatsu A, Brentjens JR, Killen PD, Kleinman HK, Martin GR, Andres GA: Studies on the formation of glomerular immune deposits in Brown Norway rats injected with mercuric chloride. Clin Immunol Immunopathol 1987; 45:35-47.
8. Aten J, Veniga A, Brujin J, Prins FA, De Heer E, Weening JJ: Antigenic specificities of glomerular-bound autoantibodies in membranous glomerulopathy induced by mercuric chloride. Clin Immunol Immunopathol 1992;63:89-102.
9. 2-induced membranous glomerulopathy. Nephrol Dial Transplant 1993;8:122-127.
10. Druet E, Guery JC, Ayed K, Guilbert B, Avrameas S, Druet P: Characteristics of polyreactivc and monospecific IgG anti-laminin autoantibodies in the rat mercury model. Immunology 1994;83:489-494.
11. Van der Meide PH, Groenestein RJ, De Labie MCDC, Aten J, Weening JJ: Susceptibility to mercuric chloride-induced glomerulonephritis is age-dependent: Study of the role of IFN-γ. Cell Immunol 1995;162:131-137.
12. Kermarrec N, Blanpied C. Pelletier L, Feingold N, Mandet C, Druet P, Hirsch F: Genetic study of gold-salt-induced immune disorders in the rat. Nephrol Dial Transplant 1995;10:2187-2191.
13. Esnault VL, Mathieson PW, Thiru S, Oliveira DB, Martin-Lockwood C: Autoantibodies to myloperoxidase in Brown Norway rats treated with mercuric chloride. Lab Invest 1992;67: 121-129.
14. Woolfson RG, Qaso FJ, Thiru S, Oliveira DB, Neild GH, Mathieson PW: Nitric oxide contributes to tissue injury in mercuric chloride-induced autoimmunity. Biochem Biophys Res Commun 1995;217:515-521.
15. Nakamura S: The role of nitric oxide in mercury chloride-induced vasculitis in the Brown Norway rat. Jpn J Nephrol 1997;39:447-454.
16. Lambracht D, Wonigeit K, Howard JC, Fisher Lindahl K: Markers for interspecies relationship in the RT1 complex. Transplant Proc 1997;29:1665-1667.
17. Canzian F: Phylogenetics of the laboratory rat Rattus norvegicus. Genome Res 1997;7:262-267.
18. Suthanthiran M, Morris RE, Strom TB: Immunosuppressants: Cellular and molecular mechanisms of action. Am J Kidney Dis 1996;28: 159-172.
19. Takabayashi K, Koike T, Kurasawa K, Matsumura R, Sato T, Tomioka H, Ito I, Yoshiki T, Yoshida S: Effect of FK 506, a novel immunosuppressive drug on murine systemic lupus erythematosus. Clin Immunol Immunopathol 1989;51:110-117.
20. Hara S, Fukatsu A, Suzuki N, Sakamoto N, Matsuo S: The effects of a new immunosuppressive agent, FK 506, on the glomerular injury in rats with accelerated nephrotoxic serum glomerulonephritis. Clin Immunol Immunopathol 1990;57:351-362.
21. Okubo Y, Tsukada Y, Maezawa A, Ono K., Yano S, Naruse T: FK 506, a novel immunosuppressive agent, induces antigen-specific immunotolerance in active Heymann's nephritis and in the autologous phase of Masugi nephritis. Clin Exp Immunol 1990;82:450-455.
22. Yamamoto K, Mori A, Nakahama T, Ito M, Okudaira H, Miyamoto T: Experimental treatment of autoimmune MRL-Ipr/Ipr mice with immunosuppressive compound FK 506. Immunology 1990;69:222-227.
23. F1 mice. Transplant Proc 1991;23: 3357-3359.
24. Matsukawa W, Hara S, Yoshida F, Suzuki N, Fukatsu A, Yuzawa Y, Sakamoto N, Matsuo S: Effects of a new immunosuppressive agent, FK 506, in rats with active Heymann nephritis. J Lab Clin Med 1992;119:116-123.
25. Entani C, Izumino K, Iida H, Fujita M, Asaka M, Takata M, Sasayama S: Effect of a novel immunosuppressant, FK 506, on spontaneous lupus nephritis in MRL/Mpj-Ipr/Ipr mice. Nephron 1993;64:471-475.
26. McCauley J, Shapiro R, Ellis D, Igdal H, Tzakis A, Starzl TE: Pilot trial of FK 506 in the treatment of steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 1993;8:1286-1290.
27. Andoh TF, Burdmann EA, Fransechini N, Houghton DC, Bennett WM: Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK 506, Kidney Int 1996;50:1110-1117.
28. Bagnis C, Deray G, Dubois M, Adabra Y, Jacquiaud C, Jaudon MC, Jacobs C: Comparative acute nephrotoxicity of FK-506 and ciclosporin in an isolated in situ autoperfused rat kidney model. Am J Nephrol 1997;17:17-24.